| - GRCh37:
- Chr6:31911323-31911344
- GRCh38:
- Chr6:31943546-31943567
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14, not provided
| Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31913046
- GRCh38:
- Chr6:31945269
| C2 | P695L, P478L, P510L, P592L, P724L | Complement component 2 deficiency, Age related macular degeneration 14, not provided, Complement component 2 deficiency | Conflicting interpretations of pathogenicity (Oct 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31902135
- GRCh38:
- Chr6:31934358
| C2 | C303Y | Complement component 2 deficiency, Age related macular degeneration 14 | Uncertain significance (Mar 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31911040
- GRCh38:
- Chr6:31943263
| C2 | N335H, N438H, N221H, N253H, N467H | Complement component 2 deficiency | Uncertain significance (May 21, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr6:31902066-31902076
- GRCh38:
- Chr6:31934289-31934299
| C2 | M251fs, M280fs, M148fs | Complement component 2 deficiency | Likely pathogenic (May 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31911430
- GRCh38:
- Chr6:31943653
| C2, CFB | K312R, K526R, K394R, K280R, K497R | Age related macular degeneration 14, not provided, Complement component 2 deficiency, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration | Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31903786
- GRCh38:
- Chr6:31936009
| C2, C2-AS1 | N66K, N180K, N283K, N312K | Age related macular degeneration 14, Complement component 2 deficiency, not provided
| Conflicting interpretations of pathogenicity (Aug 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31903779
- GRCh38:
- Chr6:31936002
| C2, C2-AS1 | N178S, N64S, N281S, N310S | Age related macular degeneration 14, Complement component 2 deficiency, not provided
| Uncertain significance (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31903763
- GRCh38:
- Chr6:31935986
| C2, C2-AS1 | L276F, L59F, L173F, L305F | Age related macular degeneration 14, Complement component 2 deficiency | Uncertain significance (Feb 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31902046
- GRCh38:
- Chr6:31934269
| C2 | | Age related macular degeneration 14, Complement component 2 deficiency, not provided
| Uncertain significance (May 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31895509
- GRCh38:
- Chr6:31927732
| C2 | | Age related macular degeneration 14, Complement component 2 deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31895494
- GRCh38:
- Chr6:31927717
| C2 | | Age related macular degeneration 14, Complement component 2 deficiency | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31913275
- GRCh38:
- Chr6:31945498
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31901976
- GRCh38:
- Chr6:31934199
| C2 | S221C, S118C, S250C | Complement component 2 deficiency, Age related macular degeneration 14, Complement component 2 deficiency, Age related macular degeneration 14, not provided | Uncertain significance (Aug 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31901383
- GRCh38:
- Chr6:31933606
| C2 | R22H | Age related macular degeneration 14, not provided, Complement component 2 deficiency
| Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31896709
- GRCh38:
- Chr6:31928932
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14, not provided
| Conflicting interpretations of pathogenicity (Oct 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31896638
- GRCh38:
- Chr6:31928861
| C2 | R100H, R129H | Complement component 2 deficiency, Age related macular degeneration 14, not provided
| Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31913075
- GRCh38:
- Chr6:31945298
| C2 | R488C, R520C, R734C, R602C, R705C | Complement component 2 deficiency, Age related macular degeneration 14, not provided
| Conflicting interpretations of pathogenicity (Oct 31, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31911054
- GRCh38:
- Chr6:31943277
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14, not provided
| Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31912582
- GRCh38:
- Chr6:31944805
| C2 | D415N, D447N, D529N, D632N, D661N | not provided, Complement component 2 deficiency, Age related macular degeneration 14
| Uncertain significance (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31907047
- GRCh38:
- Chr6:31939270
| C2, C2-AS1 | D144A, D176A, D390A, D361A, D258A | Complement component 2 deficiency, Age related macular degeneration 14, not provided
| Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31905216
- GRCh38:
- Chr6:31937439
| C2, C2-AS1 | A370V, A124V, A156V, A341V, A238V | Complement component 2 deficiency, Age related macular degeneration 14, not provided
| Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31905189
- GRCh38:
- Chr6:31937412
| C2, C2-AS1 | T229M, T147M, T361M, T115M, T332M | Complement component 2 deficiency, Age related macular degeneration 14 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31896589
- GRCh38:
- Chr6:31928812
| C2 | V84M, V113M | Age related macular degeneration 14, Complement component 2 deficiency | Uncertain significance (Mar 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31896535
- GRCh38:
- Chr6:31928758
| C2 | F66V, F95V | Complement component 2 deficiency, Age related macular degeneration 14, not provided
| Uncertain significance (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31895930
- GRCh38:
- Chr6:31928153
| C2 | A82V, R44W | Complement component 2 deficiency, Age related macular degeneration 14, not provided
| Uncertain significance (Jan 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31913420
- GRCh38:
- Chr6:31945643
| C2 | | Age related macular degeneration 14, Complement component 2 deficiency | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31911466
- GRCh38:
- Chr6:31943689
| C2 | A406V, A292V, A324V, A509V, A538V | not provided, Age related macular degeneration 14, Complement component 2 deficiency
| Conflicting interpretations of pathogenicity (Sep 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31903830
- GRCh38:
- Chr6:31936053
| C2, C2-AS1 | N298S, N327S, N195S, N81S | not provided, Age related macular degeneration 14, Complement component 2 deficiency
| Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31895834
- GRCh38:
- Chr6:31928057
| C2 | S50F, P12S | Age related macular degeneration 14, Complement component 2 deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31895794
- GRCh38:
- Chr6:31928017
| C2 | L37F | Age related macular degeneration 14, Complement component 2 deficiency | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31895758
- GRCh38:
- Chr6:31927981
| C2 | P25S | Age related macular degeneration 14, not provided, Complement component 2 deficiency
| Conflicting interpretations of pathogenicity (Jun 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31903843
- GRCh38:
- Chr6:31936066
| C2, C2-AS1 | | Age related macular degeneration 14, Complement component 2 deficiency | Uncertain significance (Mar 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31911738
- GRCh38:
- Chr6:31943961
| C2, CFB | R379Q, R461Q, R347Q, R564Q, R593Q | Complement component 2 deficiency, Age related macular degeneration 14, not provided, Atypical hemolytic-uremic syndrome | Likely benign (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31918080
- GRCh38:
- Chr6:31950303
| C2, CFB | | not specified, Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31917291
- GRCh38:
- Chr6:31949514
| C2, CFB | | Atypical hemolytic-uremic syndrome with B factor anomaly, Complement component 2 deficiency, Focal segmental glomerulosclerosis, Macular degeneration, not provided | Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31916713
- GRCh38:
- Chr6:31948936
| C2, CFB | | not provided, Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration, Complement component 2 deficiency | Benign/Likely benign (Feb 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31916707
- GRCh38:
- Chr6:31948930
| C2, CFB | | not specified, Complement component 2 deficiency, Atypical hemolytic-uremic syndrome with B factor anomaly, Complement factor b deficiency, Age related macular degeneration 14, not provided, Atypical hemolytic-uremic syndrome, Kidney disorder, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration | Benign/Likely benign (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31915819
- GRCh38:
- Chr6:31948042
| C2, CFB | | not specified, Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
| Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31915614
- GRCh38:
- Chr6:31947837
| C2, CFB | G252S | Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31915532
- GRCh38:
- Chr6:31947755
| C2, CFB | | Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome with B factor anomaly, Kidney disorder, Macular degeneration | Benign/Likely benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31915240
- GRCh38:
- Chr6:31947463
| C2, CFB | | Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31915144
- GRCh38:
- Chr6:31947367
| C2, CFB | | Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31914935
- GRCh38:
- Chr6:31947158
| C2, CFB | | Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome with B factor anomaly, Complement factor b deficiency, Macular degeneration | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31914890
- GRCh38:
- Chr6:31947113
| C2, CFB | | Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration | Benign/Likely benign (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31914306
- GRCh38:
- Chr6:31946529
| C2, CFB | R74H | Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration | Conflicting interpretations of pathogenicity (Sep 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31913438
- GRCh38:
- Chr6:31945661
| C2, CFB | | Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, Age related macular degeneration 14, Macular degeneration | Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31913317
- GRCh38:
- Chr6:31945540
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14, Macular degeneration
| Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31913254
- GRCh38:
- Chr6:31945477
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31913216
- GRCh38:
- Chr6:31945439
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14, Macular degeneration
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31913128
- GRCh38:
- Chr6:31945351
| C2 | | Complement component 2 deficiency, not provided, Age related macular degeneration 14
| Conflicting interpretations of pathogenicity (Oct 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31913076
- GRCh38:
- Chr6:31945299
| C2 | R734L, R602L, R520L, R488L, R705L | Complement component 2 deficiency, not provided, Inborn genetic diseases, Age related macular degeneration 14 | Uncertain significance (Jun 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31912947
- GRCh38:
- Chr6:31945170
| C2, CFB | | Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided, Age related macular degeneration 14, Macular degeneration | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31912773
- GRCh38:
- Chr6:31944996
| C2, CFB | | Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, Complement component 2 deficiency, Age related macular degeneration 14, not provided, Age related macular degeneration 14, Macular degeneration | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31912523
- GRCh38:
- Chr6:31944746
| C2, CFB | V641A, V509A, V395A, V612A, V427A | Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided, Age related macular degeneration 14, Macular degeneration | Benign/Likely benign (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31912009
- GRCh38:
- Chr6:31944232
| C2, CFB | | Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, not provided, Age related macular degeneration 14, Macular degeneration | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31912008
- GRCh38:
- Chr6:31944231
| C2 | | Complement component 2 deficiency, not provided, Age related macular degeneration 14, Macular degeneration | Uncertain significance (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31911936
- GRCh38:
- Chr6:31944159
| C2, CFB | S612N, S583N, S398N, S366N, S480N | Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome, Age related macular degeneration 14, Macular degeneration | Likely benign (Oct 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31911569
- GRCh38:
- Chr6:31943792
| C2 | K572N, K543N, K326N, K358N, K440N | Complement component 2 deficiency, not provided, Age related macular degeneration 14
| Uncertain significance (Aug 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31911455
- GRCh38:
- Chr6:31943678
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31911266
- GRCh38:
- Chr6:31943489
| C2, CFB | R510H, R296H, R264H, R378H, R481H | Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome, Age related macular degeneration 14, Macular degeneration | Conflicting interpretations of pathogenicity (Sep 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31911091
- GRCh38:
- Chr6:31943314
| C2, CFB | I484V, I455V, I352V, I238V, I270V | not provided, Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, Macular degeneration, Complement component 2 deficiency, Age related macular degeneration 14, Age related macular degeneration 14 | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31911055
- GRCh38:
- Chr6:31943278
| C2, CFB | A472T, A226T, A340T, A443T, A258T | Complement component 2 deficiency, not provided, Atypical hemolytic-uremic syndrome, Age related macular degeneration 14, Macular degeneration | Conflicting interpretations of pathogenicity (Oct 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31910755
- GRCh38:
- Chr6:31942978
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31906997
- GRCh38:
- Chr6:31939220
| C2, C2-AS1 | | Complement component 2 deficiency, not provided, Age related macular degeneration 14
| Conflicting interpretations of pathogenicity (Jul 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31905173
- GRCh38:
- Chr6:31937396
| C2, C2-AS1 | L356F, L142F, L224F, L110F, L327F | Complement component 2 deficiency, Age related macular degeneration 14 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31905130
- GRCh38:
- Chr6:31937353
| C2, C2-AS1 | | Complement component 2 deficiency, not provided, not specified, Age related macular degeneration 14 | Benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31896565
- GRCh38:
- Chr6:31928788
| C2 | G105R, G76R | Complement component 2 deficiency, Age related macular degeneration 14 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31895903
- GRCh38:
- Chr6:31928126
| C2 | P73L, Q35* | Complement component 2 deficiency, Age related macular degeneration 14, not provided
| Conflicting interpretations of pathogenicity (Sep 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:31895766
- GRCh38:
- Chr6:31927989
| C2 | | Complement component 2 deficiency, Macular degeneration | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31895493
- GRCh38:
- Chr6:31927716
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31895385
- GRCh38:
- Chr6:31927608
| C2 | | Complement component 2 deficiency, Age related macular degeneration 14 | Likely benign (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr6:31918468
- GRCh38:
- Chr6:31950691
| CFB | E566A | Kidney disorder, not provided, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration, Complement component 2 deficiency, Complement factor b deficiency
| Benign/Likely benign (Apr 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31918154
- GRCh38:
- Chr6:31950377
| C2, CFB | K533R | Complement factor b deficiency, Complement factor b deficiency, Atypical hemolytic-uremic syndrome with B factor anomaly, Age related macular degeneration 14, not provided, Atypical hemolytic-uremic syndrome, not specified, Complement component 2 deficiency, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31902068-31902095
- GRCh38:
- Chr6:31934289-31934316
| C2 | V281fs | C2-related disorders, Complement component 2 deficiency, Age related macular degeneration 14, not provided, Complement component 2 deficiency | Pathogenic/Likely pathogenic (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31914024
- GRCh38:
- Chr6:31946247
| C2, CFB | L9H | Complement factor b deficiency, Age related macular degeneration 14, Atypical hemolytic-uremic syndrome with B factor anomaly, not specified, not provided, Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration
| Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31914179
- GRCh38:
- Chr6:31946402
| C2, CFB | R32W | Focal segmental glomerulosclerosis, Macular degeneration, Complement component 2 deficiency, Complement factor b deficiency, Age related macular degeneration 14, Atypical hemolytic-uremic syndrome with B factor anomaly, Atypical hemolytic-uremic syndrome with B factor anomaly, not provided, Atypical hemolytic-uremic syndrome
| Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31914180
- GRCh38:
- Chr6:31946403
| C2, CFB | R32Q | Age related macular degeneration 14, Complement component 2 deficiency, not specified, not provided, Atypical hemolytic-uremic syndrome, Complement component 2 deficiency, Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration, Focal segmental glomerulosclerosis
| Benign/Likely benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:31903804
- GRCh38:
- Chr6:31936027
| C2, C2-AS1 | E318D, E72D, E186D, E289D | Age related macular degeneration 14, Complement component 2 deficiency, Age related macular degeneration 14, not specified, not provided, Complement component 2 deficiency
| Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |